Cargando…

Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection

Integrase strand transfer inhibitors (INSTI) are a main component of the current antiretroviral regimens recommended for treatment of HIV infection. However, little is known about the impact of INSTI on neurocognition and neuroimaging. We developed a prospective observational trial to evaluate the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prats, Anna, Martínez-Zalacaín, Ignacio, Mothe, Beatriz, Negredo, Eugènia, Pérez-Álvarez, Núria, Garolera, Maite, Domènech-Puigcerver, Sira, Coll, Pep, Meulbroek, Michael, Chamorro, Anna, Fumaz, Carmina R., Ferrer, Maria J., Clotet, Bonaventura, Soriano-Mas, Carles, Muñoz-Moreno, Jose A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163778/ https://www.ncbi.nlm.nih.gov/pubmed/34050221 http://dx.doi.org/10.1038/s41598-021-90678-6

Ejemplares similares

Classification Models for Neurocognitive Impairment in HIV Infection Based on Demographic and Clinical Variables
por: Muñoz-Moreno, Jose A., et al.
Publicado: (2014)

Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study
por: Muñoz-Moreno, Jose A., et al.
Publicado: (2017)

Clinical and Emotional Factors Related to Erectile Dysfunction in HIV-Infected Men
por: Fumaz, Carmina R., et al.
Publicado: (2016)

Aging in HIV-Infected Subjects: A New Scenario and a New View
por: Negredo, Eugenia, et al.
Publicado: (2017)

Cost-effectiveness analysis of the daily HIV pre-exposure prophylaxis in men who have sex with men in Barcelona
por: López Seguí, Francesc, et al.
Publicado: (2023)

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner
por: Echeverría, Patricia, et al.
Publicado: (2014)

Association between lipid genetic and immunological status in chronically HIV-infected patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Adherence and health beliefs in a psychoeducative intervention in naïve HIV-1-infected men: the PROADH study
por: Fumaz, C, et al.
Publicado: (2012)

In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial
por: Rosás-Umbert, Miriam, et al.
Publicado: (2020)

Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study
por: Mateu, Lourdes, et al.
Publicado: (2023)

High Prevalence of Sarcopenia in HIV-Infected Individuals
por: Echeverría, Patricia, et al.
Publicado: (2018)

Prescribing and using self-injectable antiretrovirals: How concordant are physician and patient perspectives?
por: Horne, Robert, et al.
Publicado: (2009)

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity
por: Bonjoch, Anna, et al.
Publicado: (2016)

Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)
por: Mothe, Beatriz, et al.
Publicado: (2019)

Corrigendum to ‘Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)’ EClinicalMedicine 11 (2019) 65–80
por: Mothe, Beatriz, et al.
Publicado: (2020)

Restrained Eating Is Associated with Lower Cortical Thickness in the Inferior Frontal Gyrus in Adolescents
por: García-García, Isabel, et al.
Publicado: (2021)

2060. Evaluation of the real world incidence of integrase inhibitor resistance since adoption as guideline preferred therapy
por: Januszka, Jenna, et al.
Publicado: (2022)

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction
por: Duran-Castells, Clara, et al.
Publicado: (2023)

Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study
por: Bonjoch, Anna, et al.
Publicado: (2016)

Remote Health Monitoring in the Workplace for Early Detection of COVID-19 Cases during the COVID-19 Pandemic Using a Mobile Health Application: COVIDApp.
por: Echeverría, Patricia, et al.
Publicado: (2021)

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)
por: Mothe, Beatriz, et al.
Publicado: (2020)

Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study
por: Echeverría, Patricia, et al.
Publicado: (2014)

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV
por: Negredo, Eugènia, et al.
Publicado: (2020)

Stable HIV-1 integrase diversity during initial HIV-1 RNA Decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy
por: Noguera-Julian, Marc, et al.
Publicado: (2013)

Viatge al Pirineu fantástic
por: Coll, Pep, 1949-
Publicado: (1996)

Integrase and integration: biochemical activities of HIV-1 integrase
por: Delelis, Olivier, et al.
Publicado: (2008)

Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile
por: Santos, José R., et al.
Publicado: (2012)

Prevalence of Ischemic Heart Disease and Management of Coronary Risk in Daily Clinical Practice: Results from a Mediterranean Cohort of HIV-Infected Patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4(+) T-cell immune recovery
por: Gómez-Mora, Elisabet, et al.
Publicado: (2017)

Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination
por: Duran-Castells, Clara, et al.
Publicado: (2023)

Time of Progression to Osteopenia/Osteoporosis in Chronically HIV-Infected Patients: Screening DXA Scan
por: Negredo, Eugenia, et al.
Publicado: (2012)

Beyond BMI: cardiometabolic measures as predictors of impulsivity and white matter changes in adolescents
por: Prunell-Castañé, Anna, et al.
Publicado: (2023)

Resistance to Integrase Inhibitors
por: Métifiot, Mathieu, et al.
Publicado: (2010)

Resistance Mutations outside the Integrase Coding Region Have an Effect on Human Immunodeficiency Virus Replicative Fitness but Do Not Affect Its Susceptibility to Integrase Strand Transfer Inhibitors
por: Weber, Jan, et al.
Publicado: (2013)

Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery
por: Massanella, Marta, et al.
Publicado: (2015)

Relationship between HIV integrase polymorphisms and integrase inhibitor susceptibility: An in silico analysis
por: Hutapea, Hotma Martogi Lorensi, et al.
Publicado: (2018)

Conversion of a dysfunctional choledochoduodenostomy to transpapillary drainage via a trans-lumen-apposing metal stent choledochoduodenoscopy
por: Gornals, Joan B., et al.
Publicado: (2023)

A New Freshwater Cyanosiphovirus Harboring Integrase
por: Zhong, Kevin Xu, et al.
Publicado: (2018)

HIV-2 Integrase Variation in Integrase Inhibitor-Naïve Adults in Senegal, West Africa
por: Gottlieb, Geoffrey S., et al.
Publicado: (2011)

HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
por: Koneru, Pratibha C, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7bqf9t5tbaff6di5pa77emv7an